Patents by Inventor Lilia Babe

Lilia Babe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GLUCOAMYLASE AND METHODS OF USE THEREOF
    Publication number: 20230340444
    Abstract: Described are a recombinant host cell, a composition comprising a glucoamylase and methods of saccharifying the starch substrate using the glucoamylase. Moreover, the disclosure also relates to a process of producing fermentation products and a method for increasing starch digestibility in an animal as well as a method of producing a fermented beverage. The glucoamylase or 1,4-alpha-D-glucan glucohydrolase (EC 3.2.1.3) is preferably from the Mucorales-clade, especially having high sequence identity to the glucoamylase from Saksenaea vasiformis.
    Type: Application
    Filed: April 19, 2021
    Publication date: October 26, 2023
    Inventors: Zhongmei TANG, Zhenghong ZHANG, Jing GE, Lilia BABE, Xingxiang XI, Helong HAO, Chao HUANG
  • GLUCOAMYLASE AND METHODS OF USE THEREOF
    Publication number: 20220396783
    Abstract: Described are a recombinant host cell, a composition comprising a glucoamylase and methods of saccharifying the starch substrate using the glucoamylase. Moreover, the disclosure also relates to a process of producing fermentation products and a method for increasing starch digestibility in an animal as well as a method of producing a fermented beverage.
    Type: Application
    Filed: April 13, 2022
    Publication date: December 15, 2022
    Inventors: Zhongmei TANG, Zhenghong ZHANG, Jing GE, Lilia BABE, Xingxiang XI, Helong HAO, Chao HUANG
  • Optimized multi-epitope constructs and uses thereof
    Publication number: 20070048330
    Abstract: The invention relates to the field of biology. In particular, it relates to multi-epitope nucleic acid and peptide vaccines and methods of designing such vaccines to provide increased immunogenicity.
    Type: Application
    Filed: October 3, 2003
    Publication date: March 1, 2007
    Inventors: Alessandro Sette, Robert Chesnut, Mark Newman, Brian Livingston, Lilia Babe, Yiyou Chen, Lawrence Deyoung, Manley Huang, Scott Power
  • Cd4+ human papillomavirus (hpv) epitopes
    Publication number: 20070037151
    Abstract: The present invention provides CD4+ T-cell epitopes in E6, E7 and E2 proteins from various strains of human papillomavirus (HPV). In some preferred embodiments, the present invention provides means for the development of HPV vaccines, in particular multivalent vaccines for the prevention of infection with high-risk HPV strains. In additional embodiments, the present invention provides means for the development of therapeutic vaccines against high-risk HPV types that prevent the development of benign and/or malignant tumors in infected individuals. The present invention further provides epitopes suitable for use in prophylactic and therapeutic vaccines.
    Type: Application
    Filed: April 23, 2004
    Publication date: February 15, 2007
    Inventors: Lilia Babe, Lawrence De Young, Fiona Harding, Manley Huang, Scott Power, Marcia Stickler
  • Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
    Publication number: 20070014810
    Abstract: This invention uses our knowledge of the mechanisms by which antigen is recognized by T cells to identify and prepare human papillomavirus (HPV) epitopes, and to develop epitope-based vaccines directed towards HPV. More specifically, this application communicates our discovery of pharmaceutical compositions and methods of use in the prevention and treatment of HPV infection.
    Type: Application
    Filed: January 3, 2005
    Publication date: January 18, 2007
    Inventors: Denise Baker, Scott Power, Mark Newman, Robert Chesnut, Scott Southwood, Bianca Mothe, Manley Huang, Lilia Babe, Lawrence DeYoung, Yiyou Chen